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İNGİLİZCE ÖZET 
The effect of intravitreal triamcinolone acetonid on retinal 
expression of VEGF, Endotelin-1, ICAM-1, E-Selektin and PECAM in 
diabetic rats  
Purpose: In this study we investigated the effect of intravitreal triamcinolone 
acetonide (IVTA) in streptozotocin-induced diabetic rats on VEGF, Endotelin-1, ICAM-1, E-
Selektin and PECAM expression inthe retina. 
Materials and Methods: Male wistar rats were included in the study. Diabetes 
was induced by intraperitoneal single injection of streptozotocin (50 mg/kg). Diabetes was 
comfirmed by measuring blood glucose level using blood samples obtained from the tail vein 
on the third and seventh days. The rats included in the study if the blood glucose level was 
higher than 250 mg/dl.  
Fifteen days after the injection of streptozotocin, a single dose of triamcinolone 
acetonide (320 µg/ 8 µl) was injected into the vitreous by using a Hamilton micro-injector (30 
gauge) and an equal volume of balanced salt solution into the fellow eyes. Rats were 
sacrificed four weeks after the injection of streptozotocin, and the eyes  were enucleated. The 
retina speciemens obtained from the enucleated eyes were examined with using VEGF, 
Endotelin-1, ICAM-1, E-Selektin and PECAM markers by immunohistochemistry. 
Results: Decreased VEGF, Endotelin-1 and PECAM expressions were found in 
some retinal layers of rats which were injected TA compared with the control rats. However, 
ICAM-1 and E-Selektin expressions was not statisticaly significant difference was found 
between TA injected and control eyes. 
Conclusion: In this study, these findings shows that intravitreal triamcinolone 
acetonide could decrased VEGF, Endotelin-1 and PECAM expression in some layers of 
diabetic rats. However no change could seen in expression of  ICAM-1 and E-Selektin. 
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